- Home
- BWB vs NMRA Comparison
BWB vs NMRA Comparison
Compare BWB & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BWB | NMRA |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 424.4M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BWB | NMRA |
|---|---|---|
| Price | $19.21 | $3.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $22.33 | $8.00 |
| AVG Volume (30 Days) | 90.1K | ★ 1.6M |
| Earning Date | 01-27-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.66 | N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $137,303,000.00 | N/A |
| Revenue This Year | $22.20 | N/A |
| Revenue Next Year | $14.52 | N/A |
| P/E Ratio | $12.88 | ★ N/A |
| Revenue Growth | ★ 29.49 | N/A |
| 52 Week Low | $11.93 | $0.61 |
| 52 Week High | $20.30 | $3.47 |
Technical Indicators
Market Signals| Indicator | BWB | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 54.08 | 77.65 |
| Support Level | $18.89 | $1.91 |
| Resistance Level | $20.30 | $3.47 |
| Average True Range (ATR) | 0.71 | 0.24 |
| MACD | -0.05 | 0.14 |
| Stochastic Oscillator | 47.14 | 82.96 |
Price Performance
Historical ComparisonAbout BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.